Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

(Mark One)

 

 

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended March 31, 2003

 

 

 

or

 

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from         to        

 

 

 

Commission File Number: 33-7106-A

 

NATURADE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

23-2442709

(State or other jurisdiction of incorporation or
organization)

 

(I. R. S. Employer Identification No.)

 

 

 

14370 Myford Rd., Irvine, California 92606

(Address of principal executive offices) (Zip code)

 

 

 

(714) 573-4800

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes  o  No  ý

 

Indicate the number of shares outstanding of the registrant’s common stock, as of the latest practicable date: 44,533,886 shares as of May 13, 2003.

 



 

FORM 10-Q

QUARTERLY REPORT

Quarter Ended March 31, 2003

TABLE OF CONTENTS

 

PART I:

FINANCIAL INFORMATION

 

 

Item 1.

Financial Statements

 

 

 

Balance Sheets as of March 31, 2003 (unaudited) and December 31, 2002 (audited)

 

 

 

Statements of Operations for the three month periods ended March 31, 2003 (unaudited) and March 31, 2002 (unaudited)

 

 

 

Statements of Cash Flows for the three months ended March 31, 2003 (unaudited) and March 31, 2002 (unaudited)

 

 

 

Notes to Financial Statements

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4.

Controls and Procedures

 

PART II:

OTHER INFORMATION

 

 

Item 1.

Legal Proceedings

 

 

Item 2.

Changes in Securities

 

 

Item 3.

Defaults Upon Senior Securities

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

 

 

Item 5.

Other Information

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

SIGNATURES

 

2



 

NATURADE, INC.

 

Balance Sheets
As of March 31, 2003 and December 31, 2002

 

 

 

March 31, 2003

 

December 31, 2002

 

 

 

(Unaudited)

 

(Audited)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

401,779

 

$

722,583

 

Accounts receivable, net

 

1,183,797

 

1,427,058

 

Inventories, net

 

1,125,239

 

1,689,131

 

Prepaid expenses and other current assets

 

256,493

 

105,135

 

Total current assets

 

2,967,308

 

3,943,907

 

 

 

 

 

 

 

Property and equipment, net

 

209,524

 

228,723

 

Other assets

 

58,594

 

49,594

 

Total assets

 

$

3,235,426

 

$

4,222,224

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

2,584,169

 

$

2,750,477

 

Accrued expenses

 

527,821

 

604,194

 

Current portion of Note Payable to Related Party

 

202,345

 

202,345

 

Current portion of long-term debt

 

1,272,996

 

1,816,662

 

Total current liabilities

 

4,587,331

 

5,373,678

 

 

 

 

 

 

 

Long-term portion of Notes Payable to Related Parties, less current maturities

 

 

 

 

 

 

 

 

 

 

 

Long-term debt, less current maturities

 

29,942

 

37,735

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

 

 

 

REDEEMABLE CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

Redeemable convertible preferred stock, Series B, less discount of $1,642,857 at March 31, 2003, and $1,714,286 at December 31, 2002, par value $0.0001 per share: authorized 50,000,000 shares; issued and outstanding, 13,540,723 at March 31, 2003 and December 31, 2002 ($2,000,000 redemption value)

 

382,666

 

256,112

 

 

 

 

 

 

 

WARRANT

 

500,000

 

500,000

 

 

 

 

 

 

 

STOCKHOLDERS’ DEFICIT:

 

 

 

 

 

Common stock, par value $0.0001 per share; authorized, 100,000,000 shares; issued and outstanding, 44,533,886 at March 31, 2003 and December 31, 2002

 

4,453

 

4,453

 

Non-Voting Common stock, par value $0.0001 per share; authorized, 2,000,000 shares; issued and outstanding, 117,284 at March 31, 2003 and December 31, 2002

 

12

 

12

 

 

 

 

 

 

 

Additional paid-in capital

 

18,987,458

 

18,987,458

 

Accumulated deficit

 

(21,256,436

)

(20,937,224

)

Total stockholders’ deficit

 

(2,264,513

)

(1,945,301

)

Total liabilities and stockholders’ deficit

 

$

3,235,426

 

$

4,222,224

 

 

See accompanying notes to financial statements.

 

3



 

NATURADE, INC

 

Statements of Operations for the Three-Month Periods
Ended March 31, 2003 and March 31, 2002

 

 

 

Three Months
Ended
March 31, 2003

 

Three Months
Ended
March 31, 2002

 

 

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

Net sales

 

$

3,866,055

 

$

3,373,016

 

 

 

 

 

 

 

Cost of sales

 

2,078,236

 

1,885,113

 

 

 

 

 

 

 

Gross profit

 

1,787,819

 

1,487,903

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

Selling, general and  administrative expenses

 

1,933,129

 

2,110,055

 

Depreciation and amortization

 

19,198

 

23,263

 

 

 

 

 

 

 

Total operating costs and expenses

 

1,952,327

 

2,133,318

 

 

 

 

 

 

 

Operating loss

 

(164,508

)